title: Sulfasalazine-induced Sweet's syndrome.
authors.affiliation: Department of Pharmacovigilance, 4002 Sousse, Tunisia.
authors.forename: Haifa Ben
authors.initials: HB
authors.lastname: Romdhane
authors.affiliation: Department of Dermatology, Farhat Hached University Hospital, 4002 Sousse, Tunisia.
authors.forename: Sana
authors.initials: S
authors.lastname: Mokni
authors.affiliation: Department of Pharmacovigilance, 4002 Sousse, Tunisia.
authors.forename: Neila
authors.initials: N
authors.lastname: Fathallah
authors.affiliation: Department of Pharmacovigilance, 4002 Sousse, Tunisia.
authors.forename: Raoudha
authors.initials: R
authors.lastname: Slim
authors.affiliation: Department of Dermatology, Farhat Hached University Hospital, 4002 Sousse, Tunisia.
authors.forename: Nadia
authors.initials: N
authors.lastname: Ghariani
authors.affiliation: Pathology Department Farhat Hached University Hospital, 4002 Sousse, Tunisia.
authors.forename: Badreddine
authors.initials: B
authors.lastname: Sriha
authors.affiliation: Department of Pharmacovigilance, 4002 Sousse, Tunisia. Electronic address: bensalem.c@gmail.com.
authors.forename: Chaker
authors.initials: C
authors.lastname: Ben Salem
mesh_terms: D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D012460:Sulfasalazine / Q000009:adverse effects*; D016463:Sweet Syndrome / Q000139:chemically induced*
chemical_list: D003879:Dermatologic Agents; D012460:Sulfasalazine
keywords: Pustulose; Pustulosis; Sulfasalazine; Sweet's syndrome; Syndrome de Sweet